Adelene Q. Perkins
2021
In 2021, Adelene Q. Perkins earned a total compensation of $1.1M as Chief Executive Officer at Infinity Pharmaceuticals, a 58% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $448,230 |
|---|---|
| Salary | $689,585 |
| Other | $11,472 |
| Total | $1,149,287 |
Perkins received $689.6K in salary, accounting for 60% of the total pay in 2021.
Perkins also received $448.2K in non-equity incentive plan and $11.5K in other compensation.
Rankings
In 2021, Adelene Q. Perkins' compensation ranked 8,296th out of 12,415 executives tracked by ExecPay. In other words, Perkins earned more than 33.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,296 out of 12,415 | 33rd |
Division Manufacturing | 3,671 out of 5,505 | 33rd |
Major group Chemicals And Allied Products | 1,634 out of 2,375 | 31st |
Industry group Drugs | 1,453 out of 2,096 | 31st |
Industry Pharmaceutical Preparations | 1,081 out of 1,546 | 30th |
Source: SEC filing on April 25, 2022.
Perkins' colleagues
We found two more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2021.